Since joining GlobalData, Magda has been creating FMCG content on a cross-sector basis including case studies and syndicated projects on product innovations and emerging market trends. Being a part of the Consumer Division, she specializes in packaging, foodservice and consumer goods industries. Magda holds an BSc Honours in Economics and MSc in Economic Policy and Analysis.
Mirko Markovic is the Growth Countries Sales Manager and International Key Account Manager at E.ON Energy Infrastructure Solutions GmbH (EIS). He plays a leading role in E.ON EIS by helping businesses around the world transition to sustainable energy. With extensive experience in international energy sales, EIS and Mirko helps large companies navigate the challenges of lowering carbon emissions, ensuring energy security and meeting new regulations.
He is particularly skilled at balancing technical infrastructure needs with financial goals in the projects. Mirko provides custom plans that cover every stage of a project. At EIS, his work focuses on, from the initial design and financing to long term operations. Together we’re delivering “Energy as a Service” models that help businesses cut costs while significantly reducing their environmental impact. By building strong international partnerships, Mirko helps organizations turn sustainability into a real competitive advantage. He is dedicated to creating future proof energy solutions that work for both the planet and our business.
As a Business Development Leader, Michael drives Decom Engineering’s global commercial strategy and regional growth across the globe. He leads high-value tendering and multimillion-pound wins, managing a global team to deliver scalable market expansion and board-level strategic insight”
Experience
Accomplished, trilingual MD, PhD clinical oncologist with 18+ years of PHARMA / CRO in different countries.
Deep knowledge in Medical Affairs and Clinical Research and development, specifically clinical trials Phase I
included first in human through Phase IV
> Skilled professional in complex aspect of oncology and molecular genetics, gastrointestinal (gastric cancer, CRC
and HCC), genitourinary cancer, skin cancer and Immunotherapy including CAR-T cell, CAR NK-cell and others)
> Prior to joining PAREXEL, roles included serving as a Senior Oncology / Hematology medical manager in Ely Lilly,
GlaxoSmithKline, ROCHE and as a Latin America Medical Scientific Liaison ASCI (Antigen Specific Cancer
Immunotherapies) for GlaxoSmithKline
> Immediate roles prior to Parexel included 2 years as Oncology / Hematology Associate Medical Director at IQVIA
Expertise
> Expertise in a variety of solid tumors indications (gastrointestinal, genitourinary and skin cancer) and immuno-
oncology and Cell & Gene therapy
> Provide scientific and strategic guidance, training and advice
> Published author in several clinical literature citations in PubMed and other short contributions in oncology books
including update and reviews
Education
> Educate and training as a Clinical Oncologist in Universidad Central de Venezuela (UCV)
PhD in molecular oncology in Instituto Venezolano de Investigaciones Cientificas (IVIC)
Aglinda Hoxha is a senior leader in wealth management, presently a Desk Head HNW at UBS Wealth Management UK. With over two decades of experience across client advisory, front‑office leadership, and risk governance, she is recognised for driving commercial growth while championing a disciplined, client‑centric control environment. Previously serving as Head of Front Office Business Risk Management, Aglinda played a pivotal role in shaping the risk and regulatory framework underpinning the UK franchise, partnering with leadership teams to turn complex requirements into practical enablers of performance. Her foundation in frontline client management—built at Barclays Wealth—continues to guide her coaching‑focused leadership style, which has supported the development of high‑performing professionals across the business. Aglinda holds an Executive MBA from the University of Cambridge and brings a strong perspective on digital innovation, scalable growth, and sustainable client value creation to her role.
Amanda’s career in clinical trial supply management has spanned over 20 years now. She got her start at a wholesaler handling named-patient import, hospital supply and specializing in global comparator sourcing. She then moved on to a CRO as the single-point of contact for drug, ancillary, and sample management for phase II-III trials with various indications and drug types, including cell therapies. In 2021 she made the jump from the service-provider to the sponsor side of things as a consultant, and is now employed at Immutep GmbH.
Stephen is a distinguished leader with over 25 years of experience advancing the fields of automation, orchestration, and intelligent workflow design. Throughout his career, he has driven large‑scale transformation programmes, helping organisations modernise operations, enhance productivity, and realise measurable efficiency gains. Known for his strategic mindset and customer‑centric approach, Stephen excels at translating complex business challenges into innovative, scalable solutions aligned to organisational goals.
His work has consistently delivered impactful outcomes—from streamlining end‑to‑end processes to shaping technology roadmaps that support long‑term growth. A trusted advisor and accomplished practitioner, he has collaborated across global teams, mentored emerging talent, and championed the adoption of next‑generation automation capabilities.
Stephen now shares his deep expertise to empower businesses to achieve sustainable success through modern, intelligent and future‑ready solutions